APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Zoster Vaccine Live

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Zoster Vaccine Live Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174048960319 December 2025177 pages

Choose your research edition.

Industry ResearchZoster Vaccine Live Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Zoster Vaccine Live Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Zoster Vaccine Live Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Zoster Vaccine Live Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Zoster Vaccine Live Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Zoster Vaccine Live market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Zoster Vaccine Live is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Zoster Vaccine Live is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Zoster Vaccine Live is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Zoster Vaccine Live is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Zoster Vaccine Live include Merck and GSK among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Zoster Vaccine Live market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Zoster Vaccine Live and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Zoster Vaccine Live sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Zoster Vaccine Live market size, projected growth trends, production technologies, key applications, and end-use industries.

Zoster Vaccine Live Segment by Company

Merck

GSK

Zoster Vaccine Live Segment by Type

Monovalent Vaccine

Combination Vaccine

Zoster Vaccine Live Segment by Application

Kids Injection

Adults Injection

Zoster Vaccine Live Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Zoster Vaccine Live market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Zoster Vaccine Live and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Zoster Vaccine Live.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Zoster Vaccine Live market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Zoster Vaccine Live manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Zoster Vaccine Live in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Zoster Vaccine Live in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Zoster Vaccine Live Industry Trends Table 2. Zoster Vaccine Live Industry Drivers Table 3. Zoster Vaccine Live Industry Opportunities and Challenges Table 4. Zoster Vaccine Live Industry Restraints Table 5. Global Zoster Vaccine Live Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Zoster Vaccine Live Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Zoster Vaccine Live Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Zoster Vaccine Live Sales Market Share by Manufacturers Table 9. Global Zoster Vaccine Live Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Zoster Vaccine Live Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Zoster Vaccine Live Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Zoster Vaccine Live Manufacturers, Product Type & Application Table 13. Global Zoster Vaccine Live Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Zoster Vaccine Live by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Monovalent Vaccine Table 17. Major Manufacturers of Combination Vaccine Table 18. Global Zoster Vaccine Live Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Zoster Vaccine Live Sales by Type (2021-2026) & (K Units) Table 20. Global Zoster Vaccine Live Sales by Type (2027-2032) & (K Units) Table 21. Global Zoster Vaccine Live Sales Market Share by Type (2021-2026) Table 22. Global Zoster Vaccine Live Sales Market Share by Type (2027-2032) Table 23. Global Zoster Vaccine Live Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Zoster Vaccine Live Revenue by Type (2021-2026) & (K Units) Table 25. Global Zoster Vaccine Live Revenue by Type (2027-2032) & (K Units) Table 26. Global Zoster Vaccine Live Revenue Market Share by Type (2021-2026) Table 27. Global Zoster Vaccine Live Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Kids Injection Table 29. Major Manufacturers of Adults Injection Table 30. Global Zoster Vaccine Live Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Zoster Vaccine Live Sales by Application (2021-2026) & (K Units) Table 32. Global Zoster Vaccine Live Sales by Application (2027-2032) & (K Units) Table 33. Global Zoster Vaccine Live Sales Market Share by Application (2021-2026) Table 34. Global Zoster Vaccine Live Sales Market Share by Application (2027-2032) Table 35. Global Zoster Vaccine Live Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Zoster Vaccine Live Revenue by Application (2021-2026) & (K Units) Table 37. Global Zoster Vaccine Live Revenue by Application (2027-2032) & (K Units) Table 38. Global Zoster Vaccine Live Revenue Market Share by Application (2021-2026) Table 39. Global Zoster Vaccine Live Revenue Market Share by Application (2027-2032) Table 40. Global Zoster Vaccine Live Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Zoster Vaccine Live Sales by Region (2021-2026) & (K Units) Table 42. Global Zoster Vaccine Live Sales Market Share by Region (2021-2026) Table 43. Global Zoster Vaccine Live Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Zoster Vaccine Live Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Zoster Vaccine Live Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Zoster Vaccine Live Sales by Country (2021-2026) & (K Units) Table 47. North America Zoster Vaccine Live Sales by Country (2027-2032) & (K Units) Table 48. Europe Zoster Vaccine Live Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Zoster Vaccine Live Sales by Country (2021-2026) & (K Units) Table 50. Europe Zoster Vaccine Live Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Zoster Vaccine Live Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Zoster Vaccine Live Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Zoster Vaccine Live Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Zoster Vaccine Live Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Zoster Vaccine Live Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Zoster Vaccine Live Sales by Country (2027-2032) & (K Units) Table 57. Global Zoster Vaccine Live Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Zoster Vaccine Live Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Zoster Vaccine Live Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Zoster Vaccine Live Revenue Market Share by Region (2021-2026) Table 61. Global Zoster Vaccine Live Revenue Market Share by Region (2027-2032) Table 62. Merck Company Information Table 63. Merck Business Overview Table 64. Merck Zoster Vaccine Live Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Merck Zoster Vaccine Live Product Portfolio Table 66. Merck Recent Development Table 67. GSK Company Information Table 68. GSK Business Overview Table 69. GSK Zoster Vaccine Live Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. GSK Zoster Vaccine Live Product Portfolio Table 71. GSK Recent Development Table 72. Key Raw Materials Table 73. Raw Materials Key Suppliers Table 74. Zoster Vaccine Live Distributors List Table 75. Zoster Vaccine Live Customers List Table 76. Research Programs/Design for This Report Table 77. Authors List of This Report Table 78. Secondary Sources Table 79. Primary Sources List of Figures Figure 1. Zoster Vaccine Live Product Image Figure 2. Global Zoster Vaccine Live Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Zoster Vaccine Live Market Size (2021-2032) & (US$ Million) Figure 4. Global Zoster Vaccine Live Sales (2021-2032) & (K Units) Figure 5. Global Zoster Vaccine Live Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Zoster Vaccine Live Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Monovalent Vaccine Image Figure 9. Combination Vaccine Image Figure 10. Global Zoster Vaccine Live Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Zoster Vaccine Live Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Zoster Vaccine Live Sales Market Share by Type (2021-2032) Figure 13. Global Zoster Vaccine Live Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Zoster Vaccine Live Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Zoster Vaccine Live Revenue Market Share by Type (2021-2032) Figure 16. Kids Injection Image Figure 17. Adults Injection Image Figure 18. Global Zoster Vaccine Live Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Zoster Vaccine Live Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Zoster Vaccine Live Sales Market Share by Application (2021-2032) Figure 21. Global Zoster Vaccine Live Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Zoster Vaccine Live Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Zoster Vaccine Live Revenue Market Share by Application (2021-2032) Figure 24. North America Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Zoster Vaccine Live Sales Market Share by Country (2021-2032) Figure 26. U.S. Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Zoster Vaccine Live Sales Market Share by Country (2021-2032) Figure 31. Germany Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Zoster Vaccine Live Sales Market Share by Country (2021-2032) Figure 38. China Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Zoster Vaccine Live Sales Market Share by Country (2021-2032) Figure 46. Brazil Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Zoster Vaccine Live Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Zoster Vaccine Live Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Zoster Vaccine Live Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Figure 57. North America Zoster Vaccine Live Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Figure 59. Europe Zoster Vaccine Live Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Zoster Vaccine Live Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Zoster Vaccine Live Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Zoster Vaccine Live Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Zoster Vaccine Live Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Zoster Vaccine Live Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Monovalent Vaccine
  • Combination Vaccine
Applications
  • Kids Injection
  • Adults Injection
Companies covered
  • Merck
  • GSK

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Zoster Vaccine Live Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Zoster Vaccine Live Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Zoster Vaccine Live Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Zoster Vaccine Live Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Zoster Vaccine Live Market Dynamics
  1. 2.1 Zoster Vaccine Live Industry Trends
  2. 2.2 Zoster Vaccine Live Industry Drivers
  3. 2.3 Zoster Vaccine Live Industry Opportunities and Challenges
  4. 2.4 Zoster Vaccine Live Industry Restraints
3 Zoster Vaccine Live Market by Manufacturers
  1. 3.1 Global Zoster Vaccine Live Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Zoster Vaccine Live Sales by Manufacturers (2021-2026)
  3. 3.3 Global Zoster Vaccine Live Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Zoster Vaccine Live Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Zoster Vaccine Live Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Zoster Vaccine Live Manufacturers, Product Type & Application
  7. 3.7 Global Zoster Vaccine Live Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Zoster Vaccine Live Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Zoster Vaccine Live Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Zoster Vaccine Live Tier 1, Tier 2, and Tier 3
4 Zoster Vaccine Live Market by Type
  1. 4.1 Zoster Vaccine Live Type Introduction
  2. 4.1.1 Monovalent Vaccine
  3. 4.1.2 Combination Vaccine
  4. 4.2 Global Zoster Vaccine Live Sales by Type
  5. 4.2.1 Global Zoster Vaccine Live Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Zoster Vaccine Live Sales by Type (2021-2032)
  7. 4.2.3 Global Zoster Vaccine Live Sales Market Share by Type (2021-2032)
  8. 4.3 Global Zoster Vaccine Live Revenue by Type
  9. 4.3.1 Global Zoster Vaccine Live Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Zoster Vaccine Live Revenue by Type (2021-2032)
  11. 4.3.3 Global Zoster Vaccine Live Revenue Market Share by Type (2021-2032)
5 Zoster Vaccine Live Market by Application
  1. 5.1 Zoster Vaccine Live Application Introduction
  2. 5.1.1 Kids Injection
  3. 5.1.2 Adults Injection
  4. 5.2 Global Zoster Vaccine Live Sales by Application
  5. 5.2.1 Global Zoster Vaccine Live Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Zoster Vaccine Live Sales by Application (2021-2032)
  7. 5.2.3 Global Zoster Vaccine Live Sales Market Share by Application (2021-2032)
  8. 5.3 Global Zoster Vaccine Live Revenue by Application
  9. 5.3.1 Global Zoster Vaccine Live Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Zoster Vaccine Live Revenue by Application (2021-2032)
  11. 5.3.3 Global Zoster Vaccine Live Revenue Market Share by Application (2021-2032)
6 Global Zoster Vaccine Live Sales by Region
  1. 6.1 Global Zoster Vaccine Live Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Zoster Vaccine Live Sales by Region (2021-2032)
  3. 6.2.1 Global Zoster Vaccine Live Sales by Region (2021-2026)
  4. 6.2.2 Global Zoster Vaccine Live Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Zoster Vaccine Live Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Zoster Vaccine Live Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Zoster Vaccine Live Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Zoster Vaccine Live Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Zoster Vaccine Live Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Zoster Vaccine Live Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Zoster Vaccine Live Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Zoster Vaccine Live Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Zoster Vaccine Live Revenue by Region
  1. 7.1 Global Zoster Vaccine Live Revenue by Region
  2. 7.1.1 Global Zoster Vaccine Live Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Zoster Vaccine Live Revenue by Region (2021-2026)
  4. 7.1.3 Global Zoster Vaccine Live Revenue by Region (2027-2032)
  5. 7.1.4 Global Zoster Vaccine Live Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Zoster Vaccine Live Revenue (2021-2032)
  8. 7.2.2 North America Zoster Vaccine Live Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Zoster Vaccine Live Revenue (2021-2032)
  11. 7.3.2 Europe Zoster Vaccine Live Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Zoster Vaccine Live Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Zoster Vaccine Live Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Zoster Vaccine Live Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Zoster Vaccine Live Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Zoster Vaccine Live Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Zoster Vaccine Live Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 GSK
  8. 8.2.1 GSK Company Information
  9. 8.2.2 GSK Business Overview
  10. 8.2.3 GSK Zoster Vaccine Live Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GSK Zoster Vaccine Live Product Portfolio
  12. 8.2.5 GSK Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Zoster Vaccine Live Value Chain Analysis
  2. 9.1.1 Zoster Vaccine Live Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Zoster Vaccine Live Production Mode & Process
  6. 9.2 Zoster Vaccine Live Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Zoster Vaccine Live Distributors
  9. 9.2.3 Zoster Vaccine Live Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst